Finally, to produce a list of proposed therapeutic targets, the list of IBD targets was intersected with the 325 controlling nodes to obtain 62 candidates (defined as IBD key nodes; Table S4) that represent genes predicted to influence IBD-associated NF-κB regulation, which had also independently been identified as IBD-associated genes or potential therapeutic targets. Here, NFKB1 is linked to inflammatory bowel disease.